Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu - 9-MTH group results

Jan 11 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2018        Nov 30, 2017     Feb 28, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              102.57              109.55           148.50    
                   (-6.4 pct)          (-0.2 pct)       (+0.4 pct)  
  Operating           15.94               20.69            24.00    
                   (-22.9 pct)         (-5.9 pct)       (-8.9 pct)  
  Recurring           17.41               22.04            26.30    
                   (-21.0 pct)         (-3.7 pct)       (-6.9 pct)  
  Net                 13.33               15.84            19.20    
                   (-15.8 pct)         (-13.6 pct)      (+0.4 pct)  
  EPS              159.35 yen          189.33 yen       229.53 yen  
  EPS Diluted      159.20 yen          189.19 yen                   
  Ann Div                               82.00 yen        82.50 yen  
  -Q2 div           41.25 yen           41.00 yen                   
  -Q4 div                               41.00 yen        41.25 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T

Recent news on Hisamitsu Pharmaceutical Co

See all news